Cover Image
市場調查報告書

照護現場脂質檢驗 (POC脂質檢驗) 的全球市場:2015∼2019年

Global POC Lipid Testing Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 325007
出版日期 內容資訊 英文 74 Pages
訂單完成後即時交付
價格
Back to Top
照護現場脂質檢驗 (POC脂質檢驗) 的全球市場:2015∼2019年 Global POC Lipid Testing Market 2015-2019
出版日期: 2015年02月25日 內容資訊: 英文 74 Pages
簡介

POC (Point of Care:照護現場) 脂質檢驗,血液中的脂質等級 (總膽固醇,LDL (低密度脂蛋白),HDL (高密度脂蛋白),測量三酸甘油酯的層級) 。因為馬上能得到分析結果,現場能提供患者治療、藥物。對應肥胖症、糖尿病、心臟病等的文明病的發病數增加,全球各國需要整備能進行POC脂質檢驗的體制。為了使POC脂質檢驗產品具成本效率性且容易使用,還有抑制診斷中的錯誤發生,而進行了標準化。。全球POC脂質檢驗市場,預計2014∼2019年,預計以6.04%的年複合成長率成長。

本報告提供全球的POC脂質檢驗 (照護現場脂質檢驗) 市場相關分析、市場概要和結構、市場規模趨勢 (今後5年的預測值)、各地區的詳細趨勢、推動、阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查、考察。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 概要

  • 全球總人口
  • 肥胖症的發病數
  • 肥胖症患者vs.(佔)人口比率

第7章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 美國的POC脂質檢驗市場
  • 歐洲的POC脂質檢驗市場
  • 波特的五力分析

第8章 各用途的市場區隔

第9章 地區區分

  • 南北美洲的POC脂質檢驗市場
  • 歐洲、中東、非洲 (EMEA) 地區的POC脂質檢驗市場
  • 亞太地區的POC脂質檢驗市場

第10章 購買標準

第11章 推動市場成長要素

第12章 成長推動因素與其影響

第13章 市場課題

第14章 成長推動因素與課題的影響

第15章 市場趨勢

第16章 趨勢與其影響

第17章 業者情勢

  • 競爭模式
    • 主要消息
    • 企業合併、收購 (M&A)
  • 供應商分析
    • 一般的產品系列
  • 其他卓越供應商

第18章 主要供應商分析

  • Abbott Laboratories
    • 主要資料
    • 產業概要
    • 各部門的市場收益額
    • 各部門的市場收益額 (過去2年份)
    • 各地區的市場收益額
    • 產業策略
    • 主要資訊
    • SWOT分析
  • Alere
  • F. Hoffmann-La Roche
  • PTS Diagnostics

第19章 相關報告

圖表一覽

目錄
Product Code: IRTNTR5375

About POC Lipid Testing

POC lipid testing helps determine blood lipid levels, which includes the measurement of total cholesterol, LDL, HDL, and triglyceride levels. The results are obtained quickly and, therefore, helps provide rapid treatments and medication to a patient. The increasing incidence of lifestyle diseases such as obesity, diabetes, and cardiac disease is responsible for establishing POC lipid testing worldwide; it is cost-effective and user-friendly. POC lipid testing products are standardized to minimize errors during testing.

TechNavio's analysts forecast the Global POC Lipid Testing market to grow at a CAGR of 6.04 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global POC Lipid Testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of POC lipid testing products used for various applications including:

  • Total cholesterol testing
  • HDL testing
  • LDL testing
  • Triglycerides testing

TechNavio's report, the Global POC Lipid Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global POC Lipid Testing market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Alere
  • F. Hoffmann-La Roche
  • PTS

Other Prominent Vendors

  • A. Menarini Diagnostics
  • Abaxis
  • Accutech
  • Acon
  • Bayer Healthcare
  • BD
  • bioMerieux
  • Bio-Rad Laboratories
  • Corgenix
  • Danaher
  • Eurotrol
  • General Life Biotechnology
  • Helena Laboratories
  • Nova Biomedical
  • OraSure Technologies
  • Quidel
  • Randox Laboratories
  • Sekisui Diagnostics
  • Siemens Healthcare
  • Sysmex
  • Trinity Biotech

Market Driver

  • Increase in Obesity and Cardiac Disorders
  • For a full, detailed list, view our report

Market Challenge

  • Threat of Laboratory Lipid Testing
  • For a full, detailed list, view our report

Market Trend

  • Increased Adoption of POC Lipid Testing
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Overview

  • 06.1. World Population
    • 06.1.1. Forecast of World Population
  • 06.2. Incidence of Obesity
    • 06.2.1. Forecast of World Population
  • 06.3. Percentage of Population Suffering from Obesity

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. POC Lipid Testing Market in US
    • 07.3.1. Market Size and Forecast
  • 07.4. POC Lipid Testing Market in Europe
    • 07.4.1. Market Size and Forecast
  • 07.5. Five Forces Analysis

08. Market Segmentation by Application

09. Geographical Segmentation

  • 09.1. POC Lipid Testing Market in Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. POC Lipid Testing Market in EMEA Region
    • 09.2.1. Market Size and Forecast
  • 09.3. POC Lipid Testing Market in APAC Region
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Vendor Analysis 2014
    • 17.2.1. Popular Products Portfolio
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Abbott Laboratories
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation by Revenue
    • 18.1.4. Business Segmentation by Revenue 2011 and 2012
    • 18.1.5. Geographical Segmentation by Revenue
    • 18.1.6. Business Strategy
    • 18.1.7. Key Information
    • 18.1.8. SWOT Analysis
  • 18.2. Alere
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation by Revenue 2013
    • 18.2.4. Business Segmentation by Revenue 2012 and 2013
    • 18.2.5. Geographical Segmentation by Revenue 2013
    • 18.2.6. Business Strategy
    • 18.2.7. Recent Developments
    • 18.2.8. SWOT Analysis
  • 18.3. F. Hoffmann-La Roche
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation
    • 18.3.4. Geographical Segmentation by Revenue 2013
    • 18.3.5. Business Strategy
    • 18.3.6. Key Information
    • 18.3.7. SWOT Analysis
  • 18.4. PTS Diagnostics
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Recent Developments
    • 18.4.4. SWOT Analysis

19. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: World Population 2014-2019 (million)
  • Exhibit 3: Incidence of Obesity 2014-2019 (million)
  • Exhibit 4: Percentage of World Population Suffering from Obesity 2014-2019
  • Exhibit 5: Global POC Lipid Testing Market 2014-2019 (US$ million)
  • Exhibit 6: POC Lipid Testing Market in US 2014-2019 (US$ million)
  • Exhibit 7: POC Lipid Testing Market in Europe 2014-2019 (US$ million)
  • Exhibit 8: Segmentation of Global POC Lipid Testing Market by Application
  • Exhibit 9: Geographical Segmentation of Global POC Lipid Testing Market 2014 and 2019
  • Exhibit 10: POC Lipid Testing Market in Americas 2014-2019 (US$ million)
  • Exhibit 11: POC Lipid Testing Market in EMEA Region 2014-2019 (US$ million)
  • Exhibit 12: POC Lipid Testing Market in APAC Region 2014-2019 (US$ million)
  • Exhibit 13: Geographical Segmentation of Global POC Lipid Testing Market 2014-2019 (US$ million)
  • Exhibit 14: Geographical Segmentation of Global POC Lipid Testing Market 2014-2019
  • Exhibit 15: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 16: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 17: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 18: Global POC Lipid Testing Market: Business Segmentation by Revenue 2013
  • Exhibit 19: Global POC Lipid Testing Market: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 20: Global POC Lipid Testing Market: Geographical Segmentation by Revenue 2013
  • Exhibit 21: F. Hoffmann-La Roche: Business Segmentation 2013
  • Exhibit 22: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 23: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals)
  • Exhibit 24: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics)
Back to Top